Onze-Lieve-Vrouwziekenhuis (OLV Ziekenhuis, OLVZ)

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R (2024) Filippi AR, Bar J, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, et al. Journal article Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2023) Barbato E, Azizi M, Schmieder R, Lauder L, Boehm M, Brouwers S, Bruno RM, et al. Journal article Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2023) Barbato E, Azizi M, Schmieder R, Lauder L, Böhm M, Brouwers S, Bruno RM, et al. Journal article Diagnostic performance of angiography-based fractional flow reserve by patient and lesion characteristics (2021) Kobayashi Y, Collet C, Achenbach S, Engstrom T, Assali A, Shlofmitz RA, Fournier S, et al. Journal article Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial (2020) Smits PC, Chang CC, Chevalier B, West NEJ, Gori T, Barbato E, Tarantini G, et al. Journal article Diagnostic Performance of Angiogram-Derived Fractional Flow Reserve: A Pooled Analysis of 5 Prospective Cohort Studies (2020) Witberg G, De Bruyne B, Fearon WF, Achenbach S, Engstrom T, Matsuo H, Kornowski R Journal article Impact of Eligibility Criteria on Clinical Outcomes of Firehawk and XIENCE Coronary Drug-Eluting Stent in an All-Comers Randomized Trial (2019) Saito Y, Wijns W, Baumbach A, Xu B, Kelbaek H, Van Royen N, Zheng M, et al. Conference contribution Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial (2019) Chang CC, Onuma Y, Chevalier B, West N, Gori T, Barbato E, Tarantini G, et al. Conference contribution Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT (2019) Van Geuns RJ, Chang CC, Chevalier B, Gori T, Barbato E, Tarantini G, Achenbach S, et al. Conference contribution 2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent (2019) Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel MA, et al. Journal article